These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 30078799)
1. [Early relapse after autologous peripheral blood stem cell transplantation in an elderly patient with enteropathy-associated T-cell lymphoma]. Sumii Y; Yamamoto K; Omura Y; Oda W; Kondo E; Oyama T; Kamoi C; Shiraishi Y; Yamamoto Y; Niiya D; Shiote Y; Imajo K Rinsho Ketsueki; 2018; 59(7):889-894. PubMed ID: 30078799 [TBL] [Abstract][Full Text] [Related]
2. Successful treatment of refractory enteropathy-associated T-cell lymphoma using high-dose chemotherapy and autologous stem cell transplantation. Ikebe T; Miyazaki Y; Abe Y; Urakami K; Ohtsuka E; Saburi Y; Saburi M; Ando T; Kohno K; Ogata M; Kadota J Intern Med; 2010; 49(19):2157-61. PubMed ID: 20930447 [TBL] [Abstract][Full Text] [Related]
3. A case of peripheral T-cell lymphoma in which therapy-related myelodysplastic syndrome developed and a second autologous transplantation was performed. Nakagawa SI; Nukii Y; Mochizuki K; Uchiyama A; Maeda Y; Kurokawa T J Clin Exp Hematop; 2024 Mar; 64(1):59-64. PubMed ID: 38417872 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report. Kouzaki H; Kitanishi T; Kitano H; Suzuki M Auris Nasus Larynx; 2004 Mar; 31(1):79-83. PubMed ID: 15041059 [TBL] [Abstract][Full Text] [Related]
5. Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysis. Raderer M; Troch M; Kiesewetter B; Püspök A; Jaeger U; Hoffmann M; Chott A Ann Hematol; 2012 Jan; 91(1):57-61. PubMed ID: 21520002 [TBL] [Abstract][Full Text] [Related]
6. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma]. Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766 [TBL] [Abstract][Full Text] [Related]
7. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. Re A; Cattaneo C; Michieli M; Casari S; Spina M; Rupolo M; Allione B; Nosari A; Schiantarelli C; Vigano M; Izzi I; Ferremi P; Lanfranchi A; Mazzuccato M; Carosi G; Tirelli U; Rossi G J Clin Oncol; 2003 Dec; 21(23):4423-7. PubMed ID: 14581441 [TBL] [Abstract][Full Text] [Related]
8. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557 [TBL] [Abstract][Full Text] [Related]
10. [Clinical outcomes of peripheral blood stem cell transplantation for aggressive peripheral T-cell lymphoma]. Huang WR; Gu ZY; Li HH; Bo J; Wang SH; Li F; Gao XN; Dou LP; Zhao Y; Jing Y; Zhu HY; Wang QS; Yu L; Gao CJ; Liu DH Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):729-733. PubMed ID: 30369182 [No Abstract] [Full Text] [Related]
11. [Successful therapy for enteropathy-associated peripheral T-cell lymphoma using high-dose polychemotherapy and autologous hematopoietic stem cell transplantation]. Vorob'ev VI; Kravchenko SK; Kovrigina AM Ter Arkh; 2013; 85(7):79-83. PubMed ID: 24137952 [TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
13. [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy]. Uematsu N; Sumi M; Kaiume H; Takeda W; Kirihara T; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H Rinsho Ketsueki; 2018; 59(1):69-74. PubMed ID: 29415941 [TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study. Thomas X; Suciu S; Rio B; Leone G; Broccia G; Fillet G; Jehn U; Feremans W; Meloni G; Vignetti M; de Witte T; Amadori S Haematologica; 2007 Mar; 92(3):389-96. PubMed ID: 17339189 [TBL] [Abstract][Full Text] [Related]
15. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center. Mikesch JH; Kuhlmann M; Demant A; Krug U; Thoennissen GB; Schmidt E; Kessler T; Schliemann C; Pohlen M; Mohr M; Evers G; Köhler G; Wessling J; Mesters R; Müller-Tidow C; Berdel WE; Thoennissen NH Ann Hematol; 2013 Aug; 92(8):1041-8. PubMed ID: 23532626 [TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases. Tsuchiyama J; Imajo K; Yoshino T; Nanba N; Toyota A; Yoshida C; Fujii K; Kondo E; Okazuka K; Hashimoto S; Toba K; Fuse I; Aizawa Y; Harada M; Tsubota T Ann Hematol; 2002 Oct; 81(10):588-92. PubMed ID: 12424541 [TBL] [Abstract][Full Text] [Related]
17. Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM). Josting A; Kàtay I; Rueffer U; Winter S; Tesch H; Engert A; Diehl V; Wickramanayake PD Ann Oncol; 1998 Mar; 9(3):289-95. PubMed ID: 9602263 [TBL] [Abstract][Full Text] [Related]
18. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy. Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567 [TBL] [Abstract][Full Text] [Related]
19. [Combination of rituximab with autologous peripheral blood stem cell transplantation for treatment of diffuse large B-cell lymphoma: a single-center experience]. Liang ZY; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Wang LH; Yin Y; Sun YH; Liu W; Wang Q; Ren HY Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1033-7. PubMed ID: 23363798 [TBL] [Abstract][Full Text] [Related]
20. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation. Gkotzamanidou M; Papadimitriou CA Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]